{"data":{"id":"us-nv/nrs-695g.1662","jurisdiction":"us-nv","citation":"NRS 695G.1662","heading":"Limitation on cost-sharing obligation for insulin covered under plan covering prescription insulin drugs.","body":"1. A managed care organization that offers or issues a health care plan which provides coverage for prescription insulin drugs shall not impose against an insured a deductible, copayment, coinsurance or other cost-sharing obligation that is greater than $35 for a 30-day supply of a prescription insulin drug which is prescribed to the insured and covered by the managed care organization, regardless of the amount or type of prescription insulin drug prescribed.\n2. As used in this section:\n(a) “Diabetes” includes type I, type II and gestational diabetes.\n(b) “Prescription insulin drug” means a prescription drug that contains insulin and is used to control blood glucose levels for the purpose of treating diabetes.","path":["TITLE 57 — INSURANCE","CHAPTER 695G - MANAGED CARE","COVERAGE BY MANAGED CARE ORGANIZATIONS"],"source_url":"https://www.leg.state.nv.us/NRS/NRS-695G.html#NRS695GSec1662","current_through":"2025 session (NRS as revised 2026-08-25)","vintage":"","retrieved_at":"2026-09-03T05:51:46Z","sha256":"a211ac7bd92769efb20552def5cd4cb85d04cc66185e015c3b952f6eaa36923a","source_id":"us-nv","stale":true,"prev":"us-nv/nrs-695g.166","next":"us-nv/nrs-695g.1665"},"notice":"GroundRules: Original legal text. Not legal advice."}